The osteocalcin gene encodes a 6-kDa polypeptide, which represents one of the most abundant noncollagenous bone proteins, and the present studies establish that osteocalcin mRNA is detected only in bone tissue. An osteocalcin gene was isolated from a rat genomic DNA library, and sequence analysis indicated that the mRNA is represented in a 953-nucleotide segment of DNA consisting of four exons and three introns. A modular organization of the 5' flanking sequences of the gene is reflected by the presence of at least three classes of regulatory elements, which include the following: (i) RNA polymerase H canonical sequences; (U) a series of consensus sequences for hormone receptor binding sites and cyclic nucleotide responsive elements consistent with physiologic expression ofthe osteocalcin gene; and (Uii) a 24-nucleotide sequence in the proximal promoter region with a CAAT motif as a central element. We have designated this highly conserved sequence as an "osteocalcin box" since only 2 nucleotide substitutions are found in the rat and human osteocalcin genes. We have demonstrated two factors regulating osteocalcin gene expression. First, a 200-fold increase occurs in normal fetal calvaria osteoblasts producing a mineralizing matrix, compared to confluent osteoblasts in a nonmineralizing matrix. Second, contained within the 600 nucleotides immediately upstream from the transcription start site are sequences that support a 10-fold stimulated transcription of the gene by 1,25-dihydroxyvitamin D.
protein have been identified, the precise function of osteocalcin is still unknown.
Osteocalcin is synthesized de novo by osteoblasts as a 10,000-kDa precursor (8) . While the majority ofthe processed osteocalcin peptide (5.7 kDa) is deposited in bone, nanogram levels are found in serum (9) . Plasma levels of osteocalcin are now widely used as a clinical parameter of osteoblast activity (10) . However, little is known regarding the factors regulating both osteocalcin gene expression and processing of the precursor. To approach an understanding of the factors modulating osteocalcin synthesis and to better define osteocalcin function, the present studies were initiated to isolate the rat osteocalcin gene. We have identified a vitamin D-responsive promoter region and find several consensus sequences for other hormones and second messengers that can regulate osteocalcin gene expression.t
MATERIALS AND METHODS
Cloning of this Rat Osteocalcin Gene. Clones were obtained by screening a recombinant fetal rat liver DNA library cloned in A Charon 4A that was provided to us by Thomas Sargent (National Institutes of Health, Bethesda, MD). The bacteriophage were grown in NC2YM medium in the LE 392 strain of Escherichia coli. Screenings were carried out in 15-cm Petri plates, each inoculated with 50,000 plaque-forming units of recombinant bacteriophage. Positive clones were selected as described by Benton and Davis (11) and plaque purified.
DNA Sequence Analysis. Overlapping segments of the osteocalcin gene were cloned into M13mp18 and sequenced by the dideoxynucleotide chain-termination method (12) . S1 Nuclease Hybridization Protection Analysis. A 207-basepair Pvu II/Hae III fragment spanning nucleotides -143 to +64 of the rat osteocalcin gene was used as a radiolabeled probe coprecipitated with 25 gg of rat calvaria total cellular RNA for analysis of the transcription initiation site. Following hybridization and S1 nuclease digestion, the doublestranded protected probe fragments were analyzed by autoradiography following double-stranded electrophoretic fractionation in 8.3 M urea/6% polyacrylamide gels (13) .
Construction of Promoter-Chloramphenicol Acetyltransferase (CAT) Fusion Genes. A vector was constructed to permit identification and to examine the regulation of promoter function, where expression of the bacterial CAT gene reflects the in vivo level of transcription. The 5' flanking sequences of the rat osteocalcin gene were inserted into the Sma I site of pUC19. The 1.6-kilobase Bgl I/BamHI fragment of pSV2CAT (14) containing the CAT protein-coding sequence was cloned into the Pst I site of the resulting plasmid.
Abbreviations: Gla, y-carboxyglutamic acid; 1,25(OH)2D3, 1,25-dihydroxyvitamin D3; CAT, chloramphenicol acetyltransferase.
Vfhe sequence reported in this paper is being deposited in the EMBL/GenBank data base (accession no. J04500).
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The fusion construct was transfected into E. coli DH5 and the supercoiled form of plasmid DNA was isolated by centrifugation in cesium chloride/ethidium bromide equilibrium (15 (14) . RNA Isolation. RNA was isolated as described from individual calvaria, long bones, and other tissues (17) of 6-week-old rats and from ROS 17.2 cells (18) . The integrity of each RNA preparation was confirmed by electrophoresis on 1% denaturing agarose gel and staining with ethidium bromide. Northern blots and slot blots were done with nitrocellulose or GeneScreenPlus membranes as described by the manufacturer (New England Nuclear, Boston, MA). Probes were labeled either by nick-translation (13) or random primer oligonucleotide labeling (19) . Following hybridization (420C-48°C) and washing, the membranes were exposed to Kodak X-Omat film. Quantitation of hybridization was done by scanning densitometry.
Osteocalcin. Medium and serum levels were determined by a radioimmunoassay (RIA) using species-specific antisera (goat anti-rat) and standards characterized in these laboratories (20) .
RESULTS AND DISCUSSION
Organization of the Rat Osteocalcin Gene. An osteocalcin gene was isolated from a rat genomic DNA library cloned in A Charon 4A using a 32P-labeled rat osteocalcin cDNA as a hybridization probe. An EcoRI/BamHI fragment containing the complete mRNA coding sequences, 800 nucleotides of 5' flanking sequences, and 1300 nucleotides of 3' sequences were subcloned in pUC19. Sequence analyses (Fig. 1) indicated that the mRNA encoding the 6-kDa osteocalcin polypeptide is represented in a 953-nucleotide segment of DNA containing four exons and three introns, which is schematically illustrated in Fig. 2 .
The in vivo transcription initiation site was established by two methods. S1 nuclease analysis was carried out using RNAs isolated from rat long bones and a 207-nucleotide 5'-32P-labeled Pvu II/Hae III segment of the gene, which spans the proximal promoter and the first 64 nucleotides of exon 1. As shown in Fig. 3 (Fig. 4) . In agreement with the presence of osteocalcin in bone and not in other tissues, detectable levels of osteocalcin gene transcripts were only observed in RNA isolated from bone (Fig.  4) . Previously low or nondetectable levels of Gla or extractable osteocalcin from tissues other than bone led to the general assumption that osteocalcin is not produced in nonosseous tissues. This is a direct demonstration that osteocalcin gene expression is bone specific. (lanes A, C, G, T) were fractionated in the same gels for assignment of the transcription start sites at single nucleotide resolution. The primary initiation site is indicated by an arrow.
Gla have been found in lung, placenta, cartilage, kidney, and liver (20) ; however, the absence ofosteocalcin mRNA confirms that the Gla in those tissues derives from vitamin K-dependent proteins other than osteocalcin.
In an in vitro system in which osteoblasts isolated from fetal rat calvaria elaborate a matrix that mineralizes during a 30-day culture period, expression of the osteocalcin gene increased 3-fold between day 16 and day 20, a period when matrix mineralization is initiating (Table 1 ). In heavily mineralized cultures (day 28, calcium = 850 + 72 ,tg; n = 3 35-mm wells) mRNA is 200-fold greater than in nonmineralized confluent osteoblast cultures (day 7, calcium = 6 + 1 Ag; n = 3 wells). Synthesized osteocalcin was 24 ± 3 ng per Iug ofDNA (n = 3 wells) on day 28 vs. 0.2 ± 0.1 ng per tug ofDNA on day 7. These increases in rat osteocalcin during matrix mineralization are consistent with increases in osteocalcin synthesis also observed in mineralizing chicken osteoblast cultures (3). Whether induction of osteocalcin mRNA during mineralization directly involves the metal ion regulatory elements (see Fig. 1 ) or is related to osteoblast differentiation that occurs during mineralization of the extracellular matrix remains to be evaluated. Also shown in Table 1 (6) . Furthermore, rats injected with 1,25(OH)2D3 showed increased mRNA levels. Serum osteocalcin levels, which reflect osteoblast synthesis of the protein (10), were as follows: control rats, 66 ± 12 ng/ml (n = 3); vitamin Ddeficient rats, 34 ± 6 ng/ml (n = 3); 1,25(OH)2D3-treated rats, 267 ± 11 ng/ml (n = 3). Therefore, osteocalcin mRNA exhibits a physiologic response to 1,25(OH)2D3 consistent with increased serum osteocalcin values and similar to osteoblasts in vitro.
The 5' Regulatory Sequence of the Osteocalcin Gene. To directly assess the contribution of 5' flanking sequences to vitamin D-modulated expression of the osteocalcin gene, the initial 600 nucleotides upstream from the transcription initiation site were fused to the mRNA coding sequences for bacterial CAT. The chimeric gene was transfected into ROS 17.2 cells and expression was assayed at 36 hr. As shown in Fig. 6 (Left) Fig. 1 , a series of putative vitamin D-responsive elements are underlined. Although not restricted to vitamin D-responsive genes, sequences rich in AGAGG and GAGA have been found in promoter and structural regions of genes encoding three vitamin D-dependent proteins-alkaline phosphatase (22) , osteonectin (23) , and calbindin (24) . The osteocalcin gene has several such sequences and the complementary nucleotide sequences (CCTCT) located in the promoter region; in introns 1, 3, and 4; in exon 2; and in the 3' flanking region (Fig. 1) .
At least three classes of regulatory elements reside in the initial 800 nucleotides upstream from the rat osteocalcin mRNA coding sequences that have the potential for influencing the specificity and/or levels of transcription of the gene. First are consensus sequences for regulatory elements associated with most genes transcribed by RNA polymerase II (25) . For example, a TATA box is found at -30, a CAAT motif, and AP1 sites (26) and AP2 (27) (30) , and vitamin D as discussed above. These are indicated in Fig. 1 . The presence of both estrogen and cAMP elements is consistent with observed changes in serum osteocalcin in estrogen-treated patients (31) and in vitro osteocalcin mRNA increases in response to parathyroid hormone and other cAMP-stimulating agents (21, 32) . Thyroid hormone also increases mRNA in T4-treated rats, while hypothyroid rats have decreased levels (33) . Although not indicated in Fig. 1 Of particular interest is a third class of regulatory elements we have identified in the proximal promoter region and designated an osteocalcin box ( Figs. 1 and 2 ). This 24-nucleotide sequence as shown below Osteocalcin promotor box: rat ATGACCCCCAATTAGTCCTGGCAG human ATGACCCCCAAATAGCCCTGGCAG contains a CAAT motif as a central core element. There are only two nucleotide substitutions between the rat and human osteocalcin gene. Despite the sequence conservation of this element in the osteocalcin gene promoter, a homologous element is not found in the proximal promoter of the vitamin D-responsive genes alkaline phosphatase (22) and calbindin (24) , suggesting a gene-specific and/or tissue-specific role for this promoter sequence. Sequences of other vitamin Dresponsive promoters and osteoblast synthesized proteins are not yet known.
In conclusion, we have identified multiple regulatory elements in the osteocalcin gene. There is evidence from in vitro and in vivo studies that these elements can potentiate expression of osteocalcin. Whether these consensus sequences function directly to affect osteocalcin gene expression or act synergistically needs to be investigated. Such an understanding of osteocalcin gene regulatory elements will both clarify existing observations and provide insight regarding osteocalcin function and the interpretation of serum osteocalcin measurements as a noninvasive bone-specific serum marker for evaluating and treating bone disorders.
